Form preview

Get the free FREEDOM OF INFORMATION SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG APPLICATION ANAD...

Get Form
This document provides a summary and approval details of the Abbreviated New Animal Drug Application for a combination of Lasalocid, Roxarsone, and Bacitracin Zinc for use in broiler chickens to prevent
We are not affiliated with any brand or entity on this form

Get, Create, Make and Sign dom of information summary

Edit
Edit your dom of information summary form online
Type text, complete fillable fields, insert images, highlight or blackout data for discretion, add comments, and more.
Add
Add your legally-binding signature
Draw or type your signature, upload a signature image, or capture it with your digital camera.
Share
Share your form instantly
Email, fax, or share your dom of information summary form via URL. You can also download, print, or export forms to your preferred cloud storage service.

How to edit dom of information summary online

9.5
Ease of Setup
pdfFiller User Ratings on G2
9.0
Ease of Use
pdfFiller User Ratings on G2
In order to make advantage of the professional PDF editor, follow these steps:
1
Check your account. If you don't have a profile yet, click Start Free Trial and sign up for one.
2
Simply add a document. Select Add New from your Dashboard and import a file into the system by uploading it from your device or importing it via the cloud, online, or internal mail. Then click Begin editing.
3
Edit dom of information summary. Text may be added and replaced, new objects can be included, pages can be rearranged, watermarks and page numbers can be added, and so on. When you're done editing, click Done and then go to the Documents tab to combine, divide, lock, or unlock the file.
4
Save your file. Select it in the list of your records. Then, move the cursor to the right toolbar and choose one of the available exporting methods: save it in multiple formats, download it as a PDF, send it by email, or store it in the cloud.
Dealing with documents is simple using pdfFiller. Try it now!

Uncompromising security for your PDF editing and eSignature needs

Your private information is safe with pdfFiller. We employ end-to-end encryption, secure cloud storage, and advanced access control to protect your documents and maintain regulatory compliance.
GDPR
AICPA SOC 2
PCI
HIPAA
CCPA
FDA

How to fill out dom of information summary

Illustration

How to fill out FREEDOM OF INFORMATION SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG APPLICATION ANADA 200-208

01
Begin by obtaining the FREEDOM OF INFORMATION SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG APPLICATION (ANADA) form.
02
Fill in the Applicant's information, including name, address, and contact details.
03
Provide a summary of the drug, including its intended use, active ingredients, and dosage form.
04
Include information about the manufacturing process and quality control measures.
05
Summarize the results of the effectiveness and safety studies.
06
Provide labeling information, including instructions for use and warning statements.
07
Include all necessary supporting documents and data to support the application.
08
Review and ensure all information is complete and accurate before submission.
09
Submit the completed application to the appropriate regulatory body.

Who needs FREEDOM OF INFORMATION SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG APPLICATION ANADA 200-208?

01
Drug manufacturers seeking approval for new animal drugs.
02
Veterinary pharmaceutical companies developing animal medications.
03
Researchers or institutions conducting studies on animal drugs.
04
Regulatory professionals involved in animal drug applications.
Fill form : Try Risk Free
Users Most Likely To Recommend - Summer 2025
Grid Leader in Small-Business - Summer 2025
High Performer - Summer 2025
Regional Leader - Summer 2025
Easiest To Do Business With - Summer 2025
Best Meets Requirements- Summer 2025
Rate the form
4.7
Satisfied
50 Votes

People Also Ask about

An Abbreviated New Drug Submission is used to obtain approval for generic drugs. This is in contrast to a New Drug Submission (NDS), which is used to obtain approval for a new brand name drug. An ANDS lists the related drug's brand name, chemical name, manufacturer name, dosage form(s), and strength(s).
NADA - A NADA is used to seek approval of a new animal drug. ANADA - An ANADA is used to seek approval of a generic new animal drug. A generic new animal drug is a copy of an approved new animal drug for which patents or other periods of exclusivity are near expiration.
NADA - A NADA is used to seek approval of a new animal drug. ANADA - An ANADA is used to seek approval of a generic new animal drug. A generic new animal drug is a copy of an approved new animal drug for which patents or other periods of exclusivity are near expiration.
The Abbreviated New Animal Drug Application (ANADA) process is for the approval of generic copies of new animal drug products that have been previously approved and shown to be safe and effective.
An abbreviated new drug application (ANDA) contains data which is submitted to FDA for the review and potential approval of a generic drug product. Once approved, an applicant may manufacture and market the generic drug product to provide a safe, effective, lower cost alternative to the brand-name drug it references.
A Freedom of Information (FOI) Summary provides the public with the key information that FDA used to determine that a New Animal Drug Application (NADA), an Abbreviated New Animal Drug Application (ANADA), or a Conditional New Animal Drug Application (CNADA) met the requirements for approval or conditional approval.
Drug Approval Information DateApplication NumberProduct Name September 19, 2024 NADA 141-585 Zenrelia (ilunocitinib tablets) September 10, 2024 ANADA 200-774 Tulaject 25 (tulathromycin injection) September 5, 2024 ANADA 200-773 Tulaject 100 (tulathromycin injection) September 5, 2024 ANADA 200-795 CARPROFEN Soft Chewable Tablets18 more rows
The FD&C Act states that an animal drug cannot be sold into interstate commerce unless it has been approved through the new animal drug application (NADA), abbreviated NADA (ANADA), or conditional approval (CNADA).

For pdfFiller’s FAQs

Below is a list of the most common customer questions. If you can’t find an answer to your question, please don’t hesitate to reach out to us.

The FREEDOM OF INFORMATION SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG APPLICATION ANADA 200-208 is a document submitted to the FDA that provides a summary of the information regarding a new animal drug application. It includes details about the drug's formulation, intended use, and data from studies demonstrating safety and effectiveness.
Veterinary pharmaceutical companies or manufacturers seeking approval to market a new animal drug must file the FREEDOM OF INFORMATION SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG APPLICATION ANADA 200-208 with the FDA.
To fill out the FREEDOM OF INFORMATION SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG APPLICATION ANADA 200-208, applicants should carefully follow the guidelines provided by the FDA, ensuring that all required sections are completed with accurate information, including drug formulation, results from clinical studies, and proposed labeling.
The purpose of the FREEDOM OF INFORMATION SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG APPLICATION ANADA 200-208 is to provide transparency in the review process of new animal drugs and to inform the public about the safety and efficacy of the drug before it is approved for market.
The information that must be reported includes details about the drug's active ingredients, manufacturing process, pharmacological properties, safety and efficacy data, labeling information, and any other relevant studies that support the application for approval.
Fill out your dom of information summary online with pdfFiller!

pdfFiller is an end-to-end solution for managing, creating, and editing documents and forms in the cloud. Save time and hassle by preparing your tax forms online.

Get started now
Form preview
If you believe that this page should be taken down, please follow our DMCA take down process here .
This form may include fields for payment information. Data entered in these fields is not covered by PCI DSS compliance.